You are searching for: hsa04371

---

T99057 Target Info	Target Name	HUMAN ERK activator kinase 1 (MEK1)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T99149 Target Info	Target Name	HUMAN ERK activator kinase 2 (MEK2)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T63816 Target Info	Target Name	Histone deacetylase 4 (HDAC4)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	PMID29671355-Compound-62	Drug Info

T16117 Target Info	Target Name	Nitric-oxide synthase brain (NOS1)
	Target type	Clinical trial Target
	Disease	Headache; Migraine;
	Drugs	NXN-462	Drug Info

T06046 Target Info	Target Name	Nitric-oxide synthase endothelial (NOS3)
	Target type	Clinical trial Target
	Disease	Myocardial infarction; Angina pectoris;
	Drugs	Tilarginine acetate	Drug Info

T02703 Target Info	Target Name	Nitric-oxide synthase inducible (NOS2)
	Target type	Clinical trial Target
	Disease	Osteoarthritis; Endotoxic shock;
	Drugs	MPL-S	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.